Skip to main content
Disciplines
Automotive Business IT + Informatics Construction + Real Estate Electrical Engineering + Electronics Energy + Sustainability Insurance + Risk Finance + Banking Management + Leadership Marketing + Sales Mechanical Engineering + Materials
Events
DE
EN
Books
Journals
Topic Page
Marketing
Start single access now
Access for companies
EXTENDED SEARCH
Log in
Top
Published in:
Cover of the book

2022 | OriginalPaper | Chapter

1. Introduction

Author : Yunjiao Zhang

Published in: Tuning Autophagy-Inducing Activity and Toxicity for Lanthanide Nanocrystals

Publisher: Springer Nature Singapore

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

In the past few decades, nanomaterials have caused a continuous and extensive research issue in different fields.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

inform now
next chapter Successfully Obtained Short Peptides RE-1 Using Phage Display Technology
Literature
1.
Nie, Z., Petukhova, A., et al. (2010). Properties and emerging applications of self-assembled structures made from inorganic nanoparticles. Nature Nanotechnology, 5(1), 15–25.CrossRef
2.
Fahlman, B. D. (2007). Materials Chemistry, 1, 282–283 (Springer, Mount Pleasant).
3.
Davis, M. E., et al. (2008). Nanoparticle therapeutics: An emerging treatment modality for cancer. Nature Review Drug Discovery, 7, 771–782.CrossRef
4.
Robby, A., et al. (2010). Strategies in the design of nanoparticles for therapeutic applications. Nature Reviews Drug Discovery, 8, 615–627.
5.
Adachi, G., Imanaka, N., & Kang, Z. C. (2004). Binary Rare Earth Oxides, 1, 125–126 (Springer, Kluwer, Academic Publishers).
6.
Bouzigues, C., Gacoin, T., et al. (2011). Biological applications of rare-earth based nanoparticles. ACS Nano, 5(11), 8488–8505.CrossRef
7.
Auzel, F., et al. (2004). Upconversion and anti-stokes processes with f and d ions in solids. Chem Reviews, 104(1), 139–173.CrossRef
8.
Bloembergen, N. (1959). Solid state infrared quantum counters. Physical Review Letters, 2, 84–85.CrossRef
9.
Auzel, F. (1966). Compteur Quantique Par Transfert D’énergie Entre Deux Ions De Terres Rares Dans Un Tungstate Mixte Et Dans Un Verre. Comptes Rendus Hebdomadaires Des Seances De L Academie Des Sciences Serie B, 262, 1016.
10.
Yu, M. X., Li, F. Y., Chen, Z. G., Hu, H., Zhan, C., Yang, H., & Huang, C. H. (2009). Laser scanning up-conversion luminescence microscopy for imaging cells labeled with rare-earth nanophosphors. Analytical Chemistry, 81(3), 930–935.CrossRef
11.
Xiong, L. Q., Chen, Z. G., Tian, Q. W., Cao, T. Y., Xu, C. J., & Huang, C. H. (2009). High contrast upconversion luminescence targeted imaging in vivo using peptide-labeled nanophosphors. Analytical Chemistry, 81(21), 8687–8694.CrossRef
12.
Hu, H., Yu, M. X., Li, F. Y., Chen, Z. G., Gao, X., Xiong, L. Q., & Huang, C. H. (2008). Facile epoxidation strategy for producing amphiphilic up-converting rare-earth nanophosphors as biological labels. Chemistry of Materials, 20(22), 7003–7009.CrossRef
13.
Michalet, X., et al. (2005). Quantum dots for live cells, in vivo imaging, and diagnostics. Science, 307(5709), 538–544.CrossRef
14.
McCarthy, J. R., et al. (2008). Multifunctional magnetic nanoparticles for targeted imaging and therapy. Advanced Drug Delivery Reviews, 60(11), 1241–1251.CrossRef
15.
Gao, J. H., et al. (2009). Multifunctional magnetic nanoparticles: Design, synthesis, and biomedical applications. Accounts of Chemical Research, 42(8), 1097–1107.CrossRef
16.
Sharma, C. S., Sarkar, S., et al. (2007). Single-walled carbon nanotubes induces oxidative stress in rat lung epithelial cells. J Nanoscience and Nanotechnology, 7(7), 2466–2472.CrossRef
17.
Toma, F. M., Sartorel, A., et al. (2010). Efficient water oxidation at carbon nanotube-polyoxometalate electrocatalytic interfaces. Nature Chemistry, 2(10), 826–831.CrossRef
18.
Yamakoshi, Y., Umezawa, N., et al. (2003). Active oxygen species generated from photoexcited fullerene (C60) as potential medicines: O2* versus 1O2. Journal of the Amerian Chemical Society, 125(42), 12803–12809.CrossRef
19.
Corona-Morales, A. A., Castell, A., et al. (2003). Fullerene C60 and ascorbic acid protect cultured chromaffin cells against levodopa toxicity. Journal of Neuroscience Research, 71(1), 121–126.CrossRef
20.
Nakanishi, I., Fukuzumi, S., et al. (2002). DNA cleavage via superoxide anion formed in photoinduced electron transfer from NADH to gamma-cyclodextrin-bicapped C-60 in an oxygen-saturated aqueous solution. Journal of Physical Chemistry, 106(9), 2372–2380.CrossRef
21.
Adlakha-Hutcheon, G., Bally, M. B., et al. (1999). Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity. Nature Biotechnology, 17(8), 775–779.CrossRef
22.
Wing, S. T., et al. (2011). Self-cleaning fibers via nanotechnology: A virtual reality. Journal of Materials Chemistry, 21(22), 7858–7869.CrossRef
23.
Deng, Z. J., et al. (2011). Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nature Nanotechnology, 6(1), 39–44.CrossRef
24.
Mikhaylov, G., Mikac, U., et al. (2011). Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment. Nature Nanotechnology, 6, 594–602.CrossRef
25.
Patra, C. R., Bhattacharya, R., et al. (2008). Pro-angiogenic properties of europium(III) hydroxide nanorods. Advanced Materials, 20(4), 753.CrossRef
26.
Hauck, T. S., Anderson, R. E., et al. (2010). In vivo quantum-dot toxicity assessment. Small (Weinheim an der Bergstrasse, Germany), 6(1), 138–144.CrossRef
27.
Wang, F., Banerjee, D., et al. (2010). Upconversion nanoparticles in biological labeling, imaging, and therapy. The Analyst, 135(8), 1839–1854.CrossRef
28.
Wang, F., Han, Y., et al. (2010). Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping. Nature, 463(7284), 1061–1065.CrossRef
29.
Idris, N. M., Li, Z. Q., Ye, L., et al. (2009). Tracking transplanted cells in live animal using upconversion fluorescent nanoparticles. Biomaterial, 30(28), 5104–5113.CrossRef
30.
Jiang, S., & Zhang, Y. (2010). Upconversion nanoparticles-based FRET system for study of SiRNA in live cells. Langmuir, 26(9), 6689–6694.CrossRef
31.
Xiong, L. Q., Chen, Z. G., et al. (2009). Synthesis, characterization, and in vivo targeted imaging of amine-functionalized rare-earth up-converting nanophosphors. Biomaterials, 30(29), 5592–5600.CrossRef
32.
Ivanova, S., Pelle, F., et al. (2008). Upconversion luminescence dynamics of Er-doped fluoride crystals for optical converters. Journal of Luminescence, 128(5), 914–917.CrossRef
33.
Suyver, J. F., Grimm, J., et al. (2006). Upconversion spectroscopy and properties of NaYF4 doped with Er (3+), Tm3+ and/or Yb3+. Journal of Luminescence, 117(1), 1–12.CrossRef
34.
Wang, L. Y., & Li, Y. D. (2006). Green upconversion nanocrystals for DNA detection. Chemical Communications, (24), 2557–2559.
35.
Lim, S. F., Riehn, R., et al. (2006). In vivo and scanning electron microscopy imaging of upconverting nanophosphors in Caenorhabditis elegans. Nano Letters, 6(2), 169–174.CrossRef
36.
Hu, H., Yu, M. X., et al. (2008). Facile epoxidation strategy for producing amphiphilic up-converting rare-earth nanophosphors as biological labels. Chemistry of Materials, 20(22), 7003–7009.CrossRef
37.
Chen, Z. G., Chen, H. L., et al. (2008). Versatile synthesis strategy for carboxylic acid-functionalized upconverting nanophosphors as biological labels. Journal of the Amerian Chemistry Society, 130(10), 3023–3029.CrossRef
38.
Liu, Z. Y., Yi, G. S., et al. (2008). Monodisperse silica nanoparticles encapsulating upconversion fluorescent and superparamagnetic nanocrystals. Chemical Communications, 6, 694–696.CrossRef
39.
Van de Rijke, F., Zijlmans, H., et al. (2001). Up-converting phosphor reporters for nucleic acid microarrays. Nature Biotechnology, 19(3), 273–276.CrossRef
40.
Corstjens, P., Zuiderwijk, M., et al. (2001). Use of up-converting phosphor reporters in lateral-flow assays to detect specific nucleic acid sequences: A rapid, sensitive DNA test to identify human papillomavirus type 16 infection. Clinical Chemistry, 47(10), 1885–1893.CrossRef
41.
Chatteriee, D. K., Rufalhah, A. J., et al. (2008). Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals. Biomaterials, 29(7), 937–943.CrossRef
42.
Zhang, P., Steelant, W., et al. (2007). Versatile photosensitizers for photodynamic therapy at infrared excitation. Journal of the American Chemistry Society, 129(15), 4526.CrossRef
43.
Chatterjee, D. K., & Yong, Z. (2008). Upconverting nanoparticles as nanotransducers for photodynamic therapy in cancer cells. Nanomedicine, 3(1), 73–82.CrossRef
44.
Idris, N. M., Gnanasammandhan, M. K., et al. (2012). In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. Nature Medicine, 18(10), 1580–1585.CrossRef
45.
Jiang, S., Zhang, Y., Lim, K. M., Sim, E. K., & Ye, L. (2009). NIR-to-visible upconversion nanoparticles for fluorescent labeling and targeted delivery of siRNA. Nanotechnology, 20(15), 155101.
46.
Lewinski, N., et al. (2008). Cytotoxicity of nanoparticles. Small (Weinheim an der Bergstrasse, Germany), 4(1), 26–49.CrossRef
47.
Nel, A., et al. (2006). Toxic potential of materials at the nanolevel. Science, 311(5761), 622–627.CrossRef
48.
Arora, S. (2011). Nanotoxicology and in vitro studies: The need of the hour. Toxicology and Applied Pharmacology, 258(2), 151–165.CrossRef
49.
Martinet, W., Schrijvers, D. M., et al. (2009). Phagocytosis of bacteria is enhanced in macrophages undergoing nutrient deprivation. FEBS Journal, 276(8), 2227–2240.CrossRef
50.
Jaeger, P. A., & Wyss-Coray, T. (2009). All-you-can-eat: Autophagy in neurodegeneration and neuroprotection. Molecular Neurodegeneration, 4, 16.CrossRef
51.
Campoy, E., & Colombo, M. I. (2009). Autophagy in intracellular bacterial infection. Biochimica Et Biophysica Acta-Molecular Cell Research, 1793(9), 1465–1477.CrossRef
52.
Takeshige, K., Baba, M., et al. (1992). Autophagy in yeast demonstrated with proteinase-deficient mutants and conditions for its induction. Journal of Cell Biology, 119(2), 301–311.CrossRef
53.
Matsuura, A., Tsukada, M., et al. (1997). Apg1p, a novel protein kinase required for the autophagic process in Saccharomyces cerevisiae. Gene, 192(2), 245–250.
54.
Mizushima, N., Yoshimori, T., et al. (2011). The role of Atg proteins in autophagosome formation. Annual Review of Cell and Developmental Biology, 27, 107–132.CrossRef
55.
Liang, X. H., et al. (1999). Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature, 402, 672–676.CrossRef
56.
57.
Klionsky, D. J. (2007). Autophagy: From phenomenology to molecular understanding in less than a decade. Nature Reviews Molecular Cell Biology, 8(11), 931–937.CrossRef
58.
Cuervo, A. M., & Dice, J. F. (1996). A receptor for the selective uptake and degradation of proteins by lysosomes. Science, 273(5274), 501–503.CrossRef
59.
Lynch-Day, M. A., Mao, K., et al. (2012). The role of autophagy in Parkinson’s disease. Cold Spring Harbor Perspectives Medicine, 2(4), a009357.
60.
Melendez, A., & Levine, B. (2009). Autophagy in C. elegans. WormBook, 1, 1–26.CrossRef
61.
Klionsky, D. T., et al. (2008). Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy, 4(2), 151–175.CrossRef
62.
Klionsky, D. T., et al. (2012). Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy, 8(4), 445–544.CrossRef
63.
Eskelinen, E. L. (2005). Maturation of autophagic vacuoles in mammalian cells. Autophagy, 1(1), 1–10.CrossRef
64.
Mizushima, N., Yoshimori, T., et al. (2010). Methods in mammalian autophagy research. Cell,140(3), 313–326.
65.
Zheng, Q., Su, H., et al. (2011). Autophagy and p62 in cardiac proteinopathy novelty and significance. Circulation Research, 109(3), 296–308.CrossRef
66.
Colosetti, P., Puissant, A., et al. (2009). Autophagy is an important event for megakaryocytic differentiation of the chronic myelogenous leukemia K562 cell line. Autophagy, 5(8), 1092–1098.CrossRef
67.
Toepfer, N., Childress, C., et al. (2011). Atorvastatin induces autophagy in prostate cancer PC3 cells through activation of LC3 transcription. Cancer Biology & Therapy, 12(8), 691–699.CrossRef
68.
Klionsky, D. J., Cuervo, A. M., et al. (2007). Methods for monitoring autophagy from yeast to human. Autophagy, 3(3), 181–206.CrossRef
69.
Pattingre, S., Petiot, A., et al. (2004). Analysis of Gα-interacting protein and activator of G-protein-signaling-3 functions in macroautophagy. Methods in Enzymology, 390, 17–31.CrossRef
70.
Bauvy, C., Meijer, A. J., et al. (2009). Assaying of autophagic protein degradation. Methods in Enzymology, 452, 47–61.CrossRef
71.
Degenhardt, K., et al. (2006). Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell, 10(1), 51–64.CrossRef
72.
Robert, T., et al. (2011). HDACs link the DNA damage response, processing of double-strand breaks and autophagy. Nature, 471, 74–79.CrossRef
73.
Liang, X. H., et al. (1999). Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature, 402(6762), 672–676.CrossRef
74.
Mathew, R., et al. (2007). Autophagy suppresses tumor progression by limiting chromosomal instability. Genes and Development, 21, 1367–1381.CrossRef
75.
Mathew, R., et al. (2009). Autophagy suppresses tumorigenesis through elimination of p62. Cell, 137, 1062–1075.CrossRef
76.
Xie, Z., et al. (2007). Autophagosome formation: Core machinery and adaptations. Nature Cell Biology, 9(10), 1102–1109.CrossRef
77.
Youle, R. J., et al. (2011). Mechanisms of mitophagy. Nature Reviews Molecular Cell Biology, 12(1), 9–14.CrossRef
78.
Guo, J., et al. (2011). Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes and Development, 25(5), 460–470.CrossRef
79.
Yang, S., et al. (2011). Pancreatic cancers require autophagy for tumor growth. Genes and Development, 25(7), 17–29.CrossRef
80.
Hu, Y., et al. (2012). Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma. Cancer Research, 72(7), 1773–1783.CrossRef
81.
Amaravadi, R., et al. (2011). Principles and current strategies for targeting autophagy for cancer treatment. Clinical Cancer Research, 17(4), 654–666.CrossRef
82.
Yang, Z., et al. (2011). The role of autophagy in cancer: Therapeutic implications. Molecular Cancer Therapeutics, 10(9), 1533–1541.CrossRef
83.
Matsuda, F., et al. (2009). Autophagy induced by 2-deoxy-D-glucose suppresses intracellular multiplication of Legionella pneumophila in A/J mouse macrophages. Autophagy, 5(4), 484–493.CrossRef
84.
Mizushima, N., et al. (2008). Autophagy fights disease through cellular self-digestion. Nature, 451(7182), 1069–1075.
85.
Lee, J. H., et al. (2010). Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell, 141(7), 1146–1191.CrossRef
86.
Wong, E. S., et al. (2008). Autophagy-mediated clearance of aggresomes is not a universal phenomenon. Human Molecular Genetics, 7(16), 2570–2582.CrossRef
87.
Vives-Bauza, C., de Vries, R. L., et al. (2010). PINK1/Parkin direct mitochondria to autophagy. Autophagy, 6(2), 315–316.
88.
Hara, T., et al. (2006). Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature, 441(7095), 885–889.CrossRef
89.
Komatsu, M., et al. (2006). Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature, 441(7095), 880–884.CrossRef
90.
Tsukamoto, S., et al. (2008). Autophagy is essential for preimplantation development of mouse embryos. Science, 321(5885), 117–120.CrossRef
91.
Al Rawi, S., et al. (2011). Postfertilization autophagy of sperm organelles prevents paternal mitochondrial DNA transmission. Science, 334(6059), 1144–1147.CrossRef
92.
Qu, X., et al. (2007). Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell, 128(5), 931–946.CrossRef
93.
Kuma, A., et al. (2004). The role of autophagy during the early neonatal starvation period. Nature, 432(7020), 1032–1036.CrossRef
94.
Paludan, C., et al. (2005). Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science, 307(5709), 593–596.CrossRef
95.
Nedjic, J., et al. (2008). Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance. Nature, 455(7211), 396–400.CrossRef
96.
Nakagawa, I., et al. (2004). Autophagy defends cells against invading group A Streptococcus. Science, 306(5698), 1037–1040.CrossRef
97.
Lee, H. K., et al. (2007). Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science, 315(5817), 1398–1401.CrossRef
98.
Singh, S. B., et al. (2006). Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science, 313(5792), 1438–1441.CrossRef
99.
Munz, C. (2010). Antigen processing via autophagy—not only for MHC class II presentation anymore? Current Opinion Immunology, 22(1), 89–93.CrossRef
100.
Levine, B., et al. (2008). Autophagy in the pathogenesis of disease. Cell, 132(1), 27–42.CrossRef
101.
Ogawa, M., et al. (2005). Escape of intracellular Shigella from autophagy. Science, 307(5710), 727–731.CrossRef
102.
Wileman, T. (2006). Aggresomes and autophagy generate sites for virus replication. Science, 312(5775), 875–878.CrossRef
103.
Virgin, H. W., et al. (2009). Autophagy genes in immunity. Nature Immunology, 10(5), 461–470.CrossRef
104.
Taylor, M. P., & Kirkegaard, K. (2007). Modification of cellular autophagy protein LC3 by poliovirus. Journal of Virology, 81(22), 12543–12553.CrossRef
105.
Brabec-Zaruba, M., et al. (2007). Induction of autophagy does not affect human rhinovirus type 2 production. Journal of Virology, 81(19), 10815–10817.CrossRef
106.
Blanchet, F. P., Moris, A., et al. (2010). Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. Immunity, 32(5), 654–669.CrossRef
107.
Nicklin, P., et al. (2009). Bidirectional transport of amino acids regulates mTOR and autophagy. Cell, 136(3), 521–534.CrossRef
108.
Singh, R., et al. (2009). Autophagy regulates lipid metabolism. Nature, 458(7242), 1131–1135.CrossRef
109.
He, C., et al. (2012). Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature, 481(7382), 511–515.CrossRef
110.
Rubinsztein, D. C., et al. (2011). Autophagy and aging. Cell, 146(5), 682–695.CrossRef
111.
Green, D. R., et al. (2011). Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science, 333(6046), 1109–1112.CrossRef
112.
Melendez, A., et al. (2003). Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science, 301(5638), 1387–1391.
113.
Johnson,T. E. (2008). Caenorhabditis elegans 2007: The premier model for the study of aging. Experimental Gerontology, 43(1), 1–4.
114.
Chen, Y., et al. (2005). Nano neodymium oxide induces massive vacuolization and autophagic cell death in non-small cell lung cancer NCI-H460 cells. Biochemical Biophysical Research Commun, 337(1), 52–60.CrossRef
115.
Seleverstov, O., et al. (2006). Quantum dots for human mesenchymal stem cells labeling. A size-dependent autophagy activation. Nano Letter, 6(12), 2826–2832.
116.
Stern, S. T., et al. (2008). Induction of autophagy in porcine kidney cells by quantum dots: A common cellular response to nanomaterials? Toxicological Sciences, 106(1), 140–152.CrossRef
117.
Zhang, Q., et al. (2009). Autophagy-mediated chemosensitization in cancer cells by fullerene C60 nanocrystal. Autophagy, 5(8), 1107–1117.CrossRef
118.
Yu, L., et al. (2009). Rare earth oxide nanocrystals induce autophagy in HeLa cells. Small (Weinheim an der Bergstrasse, Germany), 5(24), 2784–2787.CrossRef
119.
Man, N., et al. (2010). Rare earth oxide nanocrystals as a new class of autophagy inducers. Autophagy, 6(2), 310–311.CrossRef
120.
Liu, H. L., et al. (2011). A functionalized single-walled carbon nanotube-induced autophagic cell death in human lung cells through Akt-TSC2-mTOR signaling. Cell Death and Disease, 2, e159.
121.
Wei, P., et al. (2010). C60 (Nd) nanoparticles enhance chemotherapeutic susceptibility of cancer cells by modulation of autophagy. Nanotechnology, 21(49), 495101–495112.CrossRef
122.
Lee, C., et al. (2011). C60 fullerene-pentoxifylline dyad nanoparticles enhance autophagy to avoid cytotoxic effects caused by the β-amyloid peptide. Nanomedicine, 7(1), 107–114.CrossRef
123.
Zhang, Y., et al. (2010). Nano rare-earth oxides induced size-dependent vacuolization: An independent pathway from autophagy. International Journal of Nanomedicine, 5, 601–609.CrossRef
124.
Khan, M. I., et al. (2012). Induction of ROS, mitochondrial damage and autophagy in lung epithelial cancer cells by iron oxide nanoparticles. Biomaterials, 33(5), 1477–1488.CrossRef
125.
Ma, X., et al. (2011). Gold nanoparticles induce autophagosome accumulation through size-dependent nanoparticle uptake and lysosome impairment. ACS Nano, 5(11), 8629–8639.CrossRef
126.
Wu, Y. N., et al. (2011). The selective growth inhibition of oral cancer by iron core-gold shell nanoparticles through mitochondria-mediated autophagy. Biomaterials, 32(20), 4565–4573.CrossRef
127.
Li, C., et al. (2009). PAMAM nanoparticles promote acute lung injury by inducing autophagic cell death through the Akt-TSC2-mTOR signaling pathway. Journal of Molecular Cell Biology, 1(1), 37–45.CrossRef
128.
Man, N., et al. (2010). Induction of genuine autophagy by cationic lipids in mammalian cells. Autophagy, 6(4), 449–454.CrossRef
129.
Eidi, H., et al. (2012). Drug delivery by polymeric nanoparticles induced autophagy in macrophages. International Journal of Pharmaceutics, 422(1), 495–503.CrossRef
130.
Kroemer, G., et al. (2008). Autophagic cell death: The story of a misnomer. Nature Reviews Molecular Cell Biology, 9(12), 1004–1010.CrossRef
131.
Chiara Maiuri, M. (2007). Self-eating and self-killing: Crosstalk between autophagy and apoptosis. Nature Reviews Molecular Cell Biology, 8(9), 741–752.CrossRef
132.
Yang, Lu., et al. (2012). MnO nanocrystals: A platform for integration of MRI and genuine autophagy induction for chemotherapy. Advanced Functional Materials, 10, 1002.
133.
Li, J. J., Hartono, D., et al. (2010). Autophagy and oxidative stress associated with gold nanoparticles. Biomaterials, 31(23), 5996–6003.CrossRef
134.
Li, H. Y., Li, Y. H., Jiao, J., & Hu, H. M. (2011). Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumor response. Nature Nanotechnology, 6(10), 645–650.CrossRef
135.
Chiu, H. (2011). Synergistic effects of arsenic trioxide and radiation in osteosarcoma cells through the induction of both autophagy and apoptosis. Radiation Research, 175(5), 547–560.CrossRef
136.
Johnson-Lyles, D., et al. (2010). Fullerenol cytotoxicity in kidney cells is associated with cytoskeleton disruption, autophagic vacuole accumulation, and mitochondrial dysfunction. Toxicology and Applied Pharmacology, 248(3), 249–258.CrossRef
137.
Ueng, T., et al. (1997). Suppression of microsomal cytochrome P450-dependent monooxygenases and mitochondrial oxidative phosphorylation by fullerenol, a polyhydroxylated fullerene C60. Toxicology Letters, 93(1), 29–37.CrossRef
138.
Chen, H., et al. (1998). Acute and subacute toxicity study of water-soluble polyalkylsulfonated C60 in rats. Toxicologic Pathology, 26(1), 143–151.CrossRef
139.
Monick, M., et al. (2010). Identification of an autophagy defect in smokers’ alveolar macrophages. Journal of Immunology, 185(9), 5425–5435.CrossRef
140.
Chen, M. Y., et al. (2005). Surface properties, more than size, limiting convective distribution of virus-sized particles and viruses in the central nervous system. Journal of Neurosurgery, 103(2), 311–319.CrossRef
141.
Zhang, X. L., Niu, H. Y., et al. (2010). Chitosan-coated octadecyl-functionalized magnetite nanoparticles: preparation and application in extraction of trace pollutants from environmental water samples. Analytical Chemistry, 82(6), 2363–2371.CrossRef
142.
Chen, Y. J., Tao, J. A., et al. (2010). Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent. Drug Development and Industrial Pharmacy, 36(10), 1235–1244.CrossRef
143.
Alam, M. M., et al. (2010). Synthesis and characterization of TTAB coated Silver (Ag) nanoparticles. Advanced Materials Research, 264, 530–534.
144.
Whaley, S. R., English, D. S., Hu, E. L., Barbara, P. F., & Belcher, A. M. (2000). Selection of peptides with semiconductor binding specificity for directed nanocrystal assembly. Nature, 405(6787), 665–668.CrossRef
145.
Brown, S., Sarikaya, M., et al. (2000). A genetic analysis of crystal growth. Journal of Molecular Biology, 299(3), 725–735.CrossRef
146.
Giljohann, D. A., Seferos, D. S., et al. (2007). Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles. Nano Letters, 7(12), 3818–3821.CrossRef
147.
Bakota, E. L., Aulisa, L., Tsyboulski, D. A., Weisman, R. B., & Hartgerink, J. D. (2009). Multidomain peptides as single-walled carbon nanotube surfactants in cell culture. Biomacromolecules, 10(8), 2201–2206.CrossRef
148.
Kim, Y. H., Jeon, J., et al. (2011). Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125. Small (Weinheim an der Bergstrasse, Germany), 7(14), 2052–2060.CrossRef
149.
Dutta, D., et al. (2007). Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicological Sciences, 100(1), 303–315.CrossRef
150.
Smith, G. P. (1985). Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface. Science, 228, 1315–1317.CrossRef
151.
Barbas, C. F., III, Burton, D. R., Scott, J. K., & Silverman, G. J. (2001). Phage display: A laboratory manual (Cold Spring Harbour Laboratory Press, New York).
152.
Lademann, J., et al. (1999). Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacology and Applied Skin Physiology, 12, 247–256.CrossRef
153.
Lowman, H. B., et al. (1991). Selecting high-affinity binding proteins by monovalent phage display. Biochemistry, 30(45), 10832–10838.CrossRef
154.
Pasqualini, R., & Ruoslahti, E. (1996). Organ targeting in vivo using phage display peptide libraries. Nature, 380, 364–366.CrossRef
155.
Rajotte, D., et al. (1998). Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. The Journal of Clinical Investigation, 102(2), 430–437.CrossRef
156.
Bai, F., Liang, J., et al. (2007). Inhibitory effects of a specific phage-displayed peptide on high peritoneal metastasis of gastric cancer. Journal of Molecular Medcine, 85, 169–180.CrossRef
157.
Wang, S. X., et al. (2003). Selection of targets locating on the surface of epithelial ovarian cancer cells by using phage peptide library. Zhonghua Fu Chan Ke Za Zhi, 38(7), 412–414.
158.
Hsiung, P. L., et al. (2008). Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. Nature Medicine, 14(4), 454–458.CrossRef
159.
Du, Y. Z., Cai, L. L., et al. (2012). Tumor cells-specific targeting delivery achieved by A54 peptide functionalized polymeric micelles. Biomaterials, 33(34), 8858–8867.CrossRef
160.
Shukla, G. S., et al. (2005). Selection of tumor-targeting agents on freshly excised human breast tumors using a phage display library. Oncology Reports, 13(4), 757–764.
161.
Wang, Y., et al. (2003). In vivo screening and characterization of peptides specific binding to vasculature of gastric cancer. Chinese Journal of Cell Molmmunology, 19(5), 469–472.
162.
Wang, X. W., et al. (2003). Biospanning of peptide specific to P glycopmtein. Chinese Journal of Urology, 24(12), 824–826.
163.
Yao, V. J., et al. (2005). Targeting pancreatic islets with phage display assisted by laser pressure catapult microdissection. The American Journal of Pathology, 166(2), 625–636.CrossRef
164.
Wang, B., et al. (2004). Selection of targeted glioblastoma tumor cell binding and internalization peptides through phage display vector. Chinese Journal of Pathophysiology, 20(5), 752–756.
165.
Flynn, C. E., Mao, C. B., et al. (2003). Synthesis and organization of nanoscale II-VI semiconductor materials using evolved peptide specificity and viral capsid assembly. Journal of Materials Chemistry, 13(10), 2414–2421.CrossRef
166.
Lee, S. W., Mao, C. B., et al. (2002). Ordering of quantum dots using genetically engineered viruses. Science, 296(5569), 892–895.CrossRef
167.
Mao, C. B., Solis, D. J., et al. (2004). Virus-based toolkit for the directed synthesis of magnetic and semiconducting nanowires. Science, 303(5655), 213–217.CrossRef
168.
Reiss, B. D., Mao, C. B., et al. (2004). Biological routes to metal alloy ferromagnetic nanostructures. Nano Letters, 4(6), 1127–1132.CrossRef
169.
Naik, R. R., Brott, L. L., et al. (2003). Bio-inspired approaches and biologically derived materials for coatings. Progress in Organic Coatings, 47(3), 249–255.CrossRef
170.
Lee, E., Lim, Y., et al. (2008). Solution structure of peptide AG4 used to form silver nanoparticles. Biochemical adn Biophysical Research Communications, 376(3), 595–598.CrossRef
171.
Kulp, J. L., Sarikaya, M., et al. (2004). Molecular characterization of a prokaryotic polypeptide sequence that catalyzes Au crystal formation. Journal of Materials Chemistry, 14(14), 2325–2332.CrossRef
172.
Kim, J., et al. (2010). Peptide-mediated shape- and size-tunable synthesis of gold nanostructures. Acta Biomater ialia, 6(7), 2681–2689.CrossRef
173.
Sano, K. I., Sasaki, H., et al. (2005). Specificity and biomineralization activities of Ti-binding peptide-1 (TBP-1). Langmuir, 21(7), 3090–3095.CrossRef
174.
Okochi, M., Sugita, T., et al. (2010). Peptide array-based characterization and design of ZnO-high affinity peptides. Biotechnology and Bioengineering, 106(6), 845–851.CrossRef
175.
Lewin, M., et al. (2000). Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nature Biotechnology, 18(4), 410–414.CrossRef
Metadata
Title
Introduction
Author
Yunjiao Zhang
Copyright Year
2022
Publisher
Springer Nature Singapore
Book
Tuning Autophagy-Inducing Activity and Toxicity for Lanthanide Nanocrystals

Print ISBN: 978-981-16-8165-3

Electronic ISBN: 978-981-16-8166-0

Copyright Year: 2022

DOI
https://doi.org/10.1007/978-981-16-8166-0_1

Premium Partners

    Image Credits